EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Rheumatoid arthritis: pathogenesis and therapeutic advances

Ying Gao, Yunkai Zhang iD, Xingguang Liu iD

MedComm · 2024-03 · 5 (3)

DOI: 10.1002/mco2.509 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 10.03.2024. Verfasst von Ying Gao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology Changhai Hospital Naval Medical University Shanghai China. Die Arbeit wurde bisher 197-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by the unresolved synovial inflammation for tissues‐destructive consequence, which remains one of significant causes of disability and labor loss, affecting about 0.2–1% global population. Although treatments with disease‐modifying antirheumatic drugs (DMARDs) are effective to control inflammation and decrease bone destruction, the overall remission rates of RA still stay at a low level. Therefore, uncovering the pathogenesis of RA and expediting clinical transformation are imminently in need. Here, we summarize the immunological basis, inflammatory pathways, genetic and epigenetic alterations, and metabolic disorders in RA, with highlights on the abnormality of immune cells atlas, epigenetics, and immunometabolism. Besides an overview of first‐line medications including conventional DMARDs, biologics, and small molecule agents, we discuss in depth promising targeted therapies under clinical or preclinical trials, especially epigenetic and metabolic regulators. Additionally, prospects on precision medicine based on synovial biopsy or RNA‐sequencing and cell therapies of mesenchymal stem cells or chimeric antigen receptor T‐cell are also looked forward. The advancements of pathogenesis and innovations of therapies in RA accelerates the progress of RA treatments.

Schlagwörter

Stichwörter der Autor:innen

cellular metabolismepigeneticspathogenesisrheumatoid arthritistherapy

Autor:innen und Institutionen

  • Department of Rheumatology Changhai Hospital Naval Medical University Shanghai China.
  • Naval Medical Center Naval Medical University Shanghai China.
  • National Key Laboratory of Immunity & Inflammation Naval Medical University Shanghai China.
  • Department of Pathogen Biology Naval Medical University Shanghai China.

ORCID-Profile: Yunkai Zhang, Xingguang Liu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Gao, Y., Zhang, Y., & Liu, X. (2024). Rheumatoid arthritis: pathogenesis and therapeutic advances. MedComm, 5(3). https://doi.org/10.1002/mco2.509

Vancouver

Gao Y, Zhang Y, Liu X. Rheumatoid arthritis: pathogenesis and therapeutic advances. MedComm. 2024;5(3). doi:10.1002/mco2.509

BibTeX
@article{Gao2024,
  author = {Gao, Ying and Zhang, Yunkai and Liu, Xingguang},
  title = {Rheumatoid arthritis: pathogenesis and therapeutic advances},
  journal = {MedComm},
  year = {2024},
  volume = {5},
  number = {3},
  doi = {10.1002/mco2.509}
}
Kostenlos starten →